ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MOR Morphosys AG

67.85
0.00 (0.00%)
06:32:00 - Realtime Data
Share Name Share Symbol Market Type
Morphosys AG TG:MOR Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 67.85 67.80 67.90 0.00 06:32:00

MorphoSys and Celgene Create Strategic Alliance to Advance CD38 Cancer Program MOR202 for Patients with Multiple Myeloma

26/06/2013 10:58pm

Business Wire


Morphosys (TG:MOR)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Morphosys Charts.

Development of novel therapeutic antibody approach being evaluated in clinical trials for patients with multiple myeloma

MorphoSys will hold a conference call on Thursday, June 27, at 4:00pm CEST (3:00pm GMT/10:00am EDT)

  • Celgene secures worldwide rights to MOR202, whereby the companies will jointly develop MOR202 globally and co-promote the product in Europe
  • MorphoSys retains a 50/50 profit sharing in its co-promotion territory and is eligible to receive tiered double-digit royalties outside of the co-promotion territory

1 Year Morphosys Chart

1 Year Morphosys Chart

1 Month Morphosys Chart

1 Month Morphosys Chart